Mursla Bio

Cambridge, United Kingdom

Unlocking tissue-resolved multiomic biology in blood via tissue-specific extracellular vesicles (TS-EVs)

$5.0M raised

Jul 2024

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Mursla Bio raised?

Mursla Bio has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in July 2024.

Who are Mursla Bio's investors?

Mursla Bio's investors include TA Ventures, Greater London Authority.

Where is Mursla Bio headquartered?

Mursla Bio is headquartered in Cambridge, United Kingdom.

What does Mursla Bio do?

Unlocking tissue-resolved multiomic biology in blood via tissue-specific extracellular vesicles (TS-EVs)

What stage is Mursla Bio at?

Mursla Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 1, 2024.

MLA

"Mursla Bio — Funding & Investors." VCBacked, July 1, 2024, https://www.vcbacked.co/company/mursla-bio. Accessed July 2, 2026.

APA

VCBacked. (2024). Mursla Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/mursla-bio

Wikipedia (cite web)

{{cite web |title=Mursla Bio — Funding & Investors |url=https://www.vcbacked.co/company/mursla-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 1, 2024.